Arye Weigensberg - May 12, 2023 Form 4 Insider Report for Cronos Group Inc. (CRON)

Signature
/s/ Aaron B. Werner, as attorney-in-fact for Arye Weigensberg
Stock symbol
CRON
Transactions as of
May 12, 2023
Transactions value $
$0
Form type
4
Date filed
12/15/2023, 05:12 PM
Previous filing
Mar 21, 2023
Next filing
Dec 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRON COMMON SHARES Options Exercise $0 +9.01K +128.07% $0.00 16K May 12, 2023 Direct F1
transaction CRON COMMON SHARES Options Exercise $0 +3.97K +24.75% $0.00 20K May 25, 2023 Direct F1
transaction CRON COMMON SHARES Options Exercise $0 +6.42K +32.07% $0.00 26.4K Dec 13, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRON RESTRICTED STOCK UNITS Options Exercise $0 -9.01K -7.01% $0.00 119K May 12, 2023 COMMON SHARES 9.01K Direct F1, F2
transaction CRON RESTRICTED STOCK UNITS Options Exercise $0 -3.97K -3.32% $0.00 116K May 25, 2023 COMMON SHARES 3.97K Direct F1, F3
transaction CRON RESTRICTED STOCK UNITS Options Exercise $0 -6.42K -5.56% $0.00 109K Dec 13, 2023 COMMON SHARES 6.42K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc.
F2 On May 12, 2022, the reporting person was granted 27,040 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F3 On May 25, 2021, the reporting person was granted 11,917 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.
F4 On December 13, 2022, the reporting person was granted 19,266 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date.

Remarks:

Senior Vice President, Head of Research and Development